Overview
Maeve Hennessy is an Oncologist practicing medicine in Chicago, Illinois.
Dr. Hennessy is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer and Triple-Negative Breast Cancer.
She is actively involved in clinical research, co-authoring 23 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UChicago Medicine River East
Sonali Smith is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Smith is board certified in Medical Oncology and Practicing Since2001.
Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 53 years. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified).
UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park
Peter Riedell is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Riedell is highly rated in 19 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Riedell is board certified in Hematology Medical Oncology and Practicing Since2013.
Frequently Asked Questions about Dr. Maeve A. Hennessy
How do I make an appointment with Dr. Maeve A. Hennessy?
You can book an appointment with Dr. Maeve A. Hennessy by calling their office at 312-502-2904. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Maeve A. Hennessy a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maeve A. Hennessy is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Maeve A. Hennessy specialize in?
While Dr. Maeve A. Hennessy is a Oncology, they have specific expertise in Breast Cancer, Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Maeve A. Hennessy participate in research or clinical trials?
Yes. Dr. Maeve A. Hennessy has published 23 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Maeve A. Hennessy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Hennessy isAdvanced. Learn about Breast Cancer.
- Experienced
- Triple-Negative Breast CancerDr. Hennessy isExperienced. Learn about Triple-Negative Breast Cancer.